COVAXIN phase 3 data shows 78% efficacy against Covid
New Delhi, 12/9: The homegrown Covid-19 vaccine Covaxin on Thursday received long-awaited scientific credence with one of the world's top medical journals publishing the final trial…
Read More...
Read More...